Active	Status	Sponsor type	Region	Phase	Filter
7 Active 20 Inactive 27 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brilakis, Emmanouil S
GE OCT, NCT05065073: Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography	Recruiting	4	62	US	Iodixanol, Visipaque, Iohexol, Omnipaque	Minneapolis Heart Institute Foundation	Coronary Artery Disease, Contrast Media Reaction	03/23	06/23
REBIRTH, NCT04077762: Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization	Recruiting	N/A	3266	US	Radial Access, State-of-the-art femoral access with 18 gauge needle, State-of-the-art femoral access with 21 gauge needle	Minneapolis Heart Institute Foundation	Patient Satisfaction, Vascular Access Complication	08/23	08/24
NCT05440084: Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity	Not yet recruiting	N/A	30	US	Chronic total occlusion percutaneous coronary intervention	Minneapolis Heart Institute Foundation	Chronic Total Occlusion, Occlusion	09/23	09/24
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis	Recruiting	N/A	418	Europe, US, RoW	SELUTION SLR™ DEB, Control	M.A. Med Alliance S.A., Iqvia Pty Ltd	Coronary Restenosis	07/24	11/27
PROGRESS CTO, NCT02061436: Prospective Global Registry for the Study of Chronic Total Occlusion Intervention	Recruiting	N/A	2000	Europe, Canada, US, RoW		Minneapolis Heart Institute Foundation	Coronary Artery Disease	01/24	01/24
Morley, Pamela
GenePHIT, NCT05598333: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure	Recruiting	2	150	US	AB-1002, Gene Therapy, NAN-101	Asklepios Biopharmaceutical, Inc.	Congestive Heart Failure	10/26	12/30
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial	Recruiting	N/A	6500	Europe, Canada, US	AtriClip LAA Exclusion System	AtriCure, Inc., Population Health Research Institute	Ischemic Stroke, Systemic Embolism	12/31	04/32